Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance

Table 1 General information (mean ± SD)

Group	n	M/F	Age (yr)
Observation group	93	54/39	53.29 ± 9.49
Control group	40	27/13	52.17 ± 8.14
t/χ2		1.046	0.65
P value		> 0.05	> 0.05

Table 2 Relationship between Annexin A5 and clinicopathological features of patients with colon cancer n (%)

Clinicopathological feature	n	Positive	χ2	P value
Gender
M	54	31 (57.41)	0.023	> 0.05
F	39	23 (58.97)
Age, yr
≥ 55	47	29 (61.70)	0.516	> 0.05
< 50	46	25 (54.35)
Lymph node metastasis
Yes	29	23 (79.31)	7.812	< 0.05
No	64	31 (48.44)
Tumor diameter (cm)
≥ 5	51	29 (56.86)	0.067	> 0.05
< 5	42	25 (59.52)
Tumor stage
I to II	47	14 (29.79)	31.204	< 0.05
III to IV	46	40 (86.96)

Table 3 Serum levels of Annexin A5 in the two groups (mean ± SD, ng/mL)

Group	n	Annexin A5	t	P value
Observation group	93	0.184 ± 0.043	2.904	< 0.05
Control group	40	0.159 ± 0.051